Miller Vein First to Perform FDA-Approved VenaSeal™ Treatment in Southeast Michigan, A Nonsurgical Solution to Treat Varicose Veins

venasealMiller Vein, Metro-Detroit’s primary vein clinic, now offers patients VenaSeal™ as a treatment option for varicose veins. Jeffrey H. Miller, MD and his staff performed the first treatment in Southeast Michigan on Thursday, February 11, 2016. The VenaSeal™ closure system uses a “medical-superglue” to close diseased veins in patients with venous reflux disease.

VenaSeal™ is a variation of procedures already performed at Miller Vein. The benefits of VenaSeal™ is there is only one numbing injection, no compression stockings are needed after the procedure, and patients are able to exercise immediately.

While the underlying cause of varicose veins, venous insufficiency is considered medical; this new form of treatment is currently not covered by insurance.

The VenaSeal™ closure system is the only non-tumescent, non-thermal, non-sclerosant procedure that uses an exclusive medical adhesive delivered endovenously to close the vein. This unique approach eliminates the risk of nerve injury when treating the diseased vein, which is a risk sometimes associated with certain thermal-based procedures. Clinical studies have demonstrated that the procedure is safe and effective. The procedure is administered without the use of local anesthesia, avoiding patient discomfort associated with multiple needle sticks.

Click here to see VenaSeal™ featured on “The Dr. Oz Show”.